A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have B ...
Phase III, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Have Been Previously Exposed to TNF Inhibitors Phase III, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etroliz ...
Ulcerative Colitis
Drug: Etrozulimab;Drug: Placebo
Hoffmann-La Roche
NULL
Completed
18 Years
80 Years
All
609
Phase 3
United States;Argentina;Australia;Austria;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;Netherlands;Poland;Romania;Spain;Switzerland;United Kingdom;Czech Republic;New Zealand United States;Argentina;Australia;Austria;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greec ...